Aleen D. Saxton

510 total citations
17 papers, 287 citations indexed

About

Aleen D. Saxton is a scholar working on Physiology, Molecular Biology and Aging. According to data from OpenAlex, Aleen D. Saxton has authored 17 papers receiving a total of 287 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Physiology, 8 papers in Molecular Biology and 7 papers in Aging. Recurrent topics in Aleen D. Saxton's work include Alzheimer's disease research and treatments (10 papers), Genetics, Aging, and Longevity in Model Organisms (7 papers) and Amyotrophic Lateral Sclerosis Research (4 papers). Aleen D. Saxton is often cited by papers focused on Alzheimer's disease research and treatments (10 papers), Genetics, Aging, and Longevity in Model Organisms (7 papers) and Amyotrophic Lateral Sclerosis Research (4 papers). Aleen D. Saxton collaborates with scholars based in United States, Australia and Germany. Aleen D. Saxton's co-authors include Brian C. Kraemer, Timothy J. Strovas, C. Dirk Keene, Nicole F. Liachko, Thomas D. Bird, Pamela J. McMillan, Lesley Leong, Martin Darvas, Thomas J. Montine and Jeremy D. Baker and has published in prestigious journals such as PLoS ONE, Brain and Scientific Reports.

In The Last Decade

Aleen D. Saxton

15 papers receiving 283 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Aleen D. Saxton United States	10	139	97	55	46	28	17	287
Moon-Yong Cha United States	2	176 1.3×	81 0.8×	35 0.6×	19 0.4×	8 0.3×	2	338
Chrysanthi Samara Greece	7	221 1.6×	63 0.6×	17 0.3×	177 3.8×	10 0.4×	10	491
Franca Mazzucchelli Italy	6	210 1.5×	53 0.5×	38 0.7×	30 0.7×	2 0.1×	6	273
Tomoyo Sawada Japan	6	357 2.6×	99 1.0×	194 3.5×	17 0.4×	8 0.3×	7	525
Theodora Saridaki Germany	11	120 0.9×	101 1.0×	157 2.9×	4 0.1×	16 0.6×	11	397
Yury O. Núnez United States	9	265 1.9×	85 0.9×	12 0.2×	16 0.3×	41 1.5×	10	507
Sara Al Rawi France	6	304 2.2×	35 0.4×	32 0.6×	93 2.0×	18 0.6×	9	479
Rashmi U. Pathak India	10	227 1.6×	52 0.5×	10 0.2×	11 0.2×	3 0.1×	19	310
Sasha De Henau Belgium	11	273 2.0×	77 0.8×	16 0.3×	155 3.4×	4 0.1×	16	447
Philip L. DeJager United States	3	131 0.9×	46 0.5×	34 0.6×	6 0.1×	6 0.2×	3	272

Countries citing papers authored by Aleen D. Saxton

Since Specialization

Citations

This map shows the geographic impact of Aleen D. Saxton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aleen D. Saxton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aleen D. Saxton more than expected).

Fields of papers citing papers by Aleen D. Saxton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aleen D. Saxton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aleen D. Saxton. The network helps show where Aleen D. Saxton may publish in the future.

Co-authorship network of co-authors of Aleen D. Saxton

This figure shows the co-authorship network connecting the top 25 collaborators of Aleen D. Saxton. A scholar is included among the top collaborators of Aleen D. Saxton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aleen D. Saxton. Aleen D. Saxton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

McMillan, Pamela J., et al.. (2026). Calcineurin depletion coincides with phosphorylated TDP-43 deposition in a mouse model of ALS/FTLD-TDP. Acta Neuropathologica Communications. 14(1). 33–33.

Saxton, Aleen D., et al.. (2024). Endoplasmic reticulum unfolded protein response transcriptional targets of XBP-1s mediate rescue from tauopathy. Communications Biology. 7(1). 903–903. 3 indexed citations

Saxton, Aleen D., et al.. (2024). TMEM106B C‐terminal fragments aggregate and drive neurodegenerative proteinopathy in transgenic Caenorhabditis elegans. Alzheimer s & Dementia. 21(2). e14468–e14468. 1 indexed citations

Saxton, Aleen D., et al.. (2024). Activation of the heat shock response as a therapeutic strategy for tau toxicity. Disease Models & Mechanisms. 17(9). 1 indexed citations

Saxton, Aleen D., et al.. (2024). Transgenic Dendra2::tau expression allows in vivo monitoring of tau proteostasis in Caenorhabditis elegans. Disease Models & Mechanisms. 17(3). 3 indexed citations

McMillan, Pamela J., Aleen D. Saxton, Timothy J. Strovas, et al.. (2023). Tau–RNA complexes inhibit microtubule polymerization and drive disease-relevant conformation change. Brain. 146(8). 3206–3220. 18 indexed citations

Saxton, Aleen D., et al.. (2022). Loss of aly/ALYREF suppresses toxicity in both tau and TDP-43 models of neurodegeneration. GeroScience. 44(2). 747–761. 9 indexed citations

Saxton, Aleen D. & Brian C. Kraemer. (2021). Human Ubiquilin 2 and TDP-43 copathology drives neurodegeneration in transgenic Caenorhabditis elegans. G3 Genes Genomes Genetics. 11(8). 5 indexed citations

Chen, Sunny, Lesley Leong, Aleen D. Saxton, et al.. (2020). Redefining transcriptional regulation of the APOE gene and its association with Alzheimer’s disease. PLoS ONE. 15(1). e0227667–e0227667. 35 indexed citations

10.

Baker, Jeremy D., et al.. (2020). AlphaScreen Identifies MSUT2 Inhibitors for Tauopathy-Targeting Therapeutic Discovery. SLAS DISCOVERY. 26(3). 400–409. 2 indexed citations

11.

Strovas, Timothy J., Pamela J. McMillan, Ashley M. Jacobi, et al.. (2020). Distinct Poly(A) nucleases have differential impact on sut-2 dependent tauopathy phenotypes.. Neurobiology of Disease. 147. 105148–105148. 14 indexed citations

12.

Baker, Jeremy D., et al.. (2020). Targeting Pathological Tau by Small Molecule Inhibition of the Poly(A):MSUT2 RNA–Protein Interaction. ACS Chemical Neuroscience. 11(15). 2277–2285. 20 indexed citations

13.

Liachko, Nicole F., Aleen D. Saxton, Pamela J. McMillan, et al.. (2019). Genome wide analysis reveals heparan sulfate epimerase modulates TDP-43 proteinopathy. PLoS Genetics. 15(12). e1008526–e1008526. 12 indexed citations

14.

Strovas, Timothy J., et al.. (2019). Synergistic toxicity between tau and amyloid drives neuronal dysfunction and neurodegeneration in transgenic C. elegans. Human Molecular Genetics. 29(3). 495–505. 22 indexed citations

15.

Weeks, Janis C., William M. Roberts, Brian M. Suzuki, et al.. (2018). Sertraline, Paroxetine, and Chlorpromazine Are Rapidly Acting Anthelmintic Drugs Capable of Clinical Repurposing. Scientific Reports. 8(1). 975–975. 50 indexed citations

16.

Liachko, Nicole F., Aleen D. Saxton, Pamela J. McMillan, et al.. (2016). The phosphatase calcineurin regulates pathological TDP-43 phosphorylation. Acta Neuropathologica. 132(4). 545–561. 39 indexed citations

17.

Yu, Chang-En, Eiron Cudaback, Jessica Foraker, et al.. (2013). Epigenetic signature and enhancer activity of the human APOE gene. Human Molecular Genetics. 22(24). 5036–5047. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact